ACTRN12617000282381撤回未知
An open-label, feasibility study of Menaquinone-7 enriched supplement in haemodialysis patients.
适应症
试验速览
- 阶段
- 未知
- 状态
- 撤回
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study to find and investigate a safe dose of BI 836858 in combination with decitabine for patients with acute myeloid leukemia (AML)patients with acute myeloid leukemiaMedDRA version: 19.1Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000004864EUCTR2015-002892-30-ESBoehringer Ingelheim España, S.A.200
进行中（未招募）
1 期
A study to find and investigate a safe dose of BI 836858 in combination with decitabine for patients with acute myeloid leukemia (AML)patients with acute myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000004864EUCTR2015-002892-30-ITBOEHRINGER-INGELHEIM ITALIA S.P.A.200
进行中（未招募）
1 期
A study to find and investigate a safe dose of BI 836858 in combination with decitabine for patients with acute myeloid leukemia (AML)patients with acute myeloid leukemiaMedDRA version: 20.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000004864EUCTR2015-002892-30-DEBoehringer Ingelheim Pharma GmbH & Co. KG220
尚未招募
4 期
Study of Mycobacterium in Adjuvant Setting in Advanced Stage of Lung Cancer.CTRI/2020/09/027853Tata Memorial Hospital
进行中（未招募）
4 期
Are anti-viral medications (remdesivir) a safe and feasible drug to improve outcomes for those living with Long COVID?Post COVID-19 condition, post COVID syndrome and/or Long COVIDInfections and InfestationsISRCTN72940450niversity of Derby72